Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CTMX |
---|---|---|
09:32 ET | 66766 | 1.42 |
09:34 ET | 4937 | 1.44 |
09:36 ET | 5000 | 1.45 |
09:38 ET | 1825 | 1.4417 |
09:41 ET | 2425 | 1.4416 |
09:43 ET | 2150 | 1.45 |
09:45 ET | 1600 | 1.45 |
09:48 ET | 4562 | 1.45 |
09:50 ET | 679 | 1.45 |
09:52 ET | 3546 | 1.43 |
09:54 ET | 3188 | 1.425 |
09:56 ET | 14293 | 1.42 |
09:57 ET | 500 | 1.4199 |
09:59 ET | 100 | 1.415 |
10:01 ET | 3880 | 1.416 |
10:06 ET | 2200 | 1.43 |
10:08 ET | 300 | 1.41 |
10:10 ET | 207 | 1.41 |
10:12 ET | 4841 | 1.425 |
10:14 ET | 3600 | 1.41 |
10:15 ET | 3170 | 1.41 |
10:17 ET | 400 | 1.41 |
10:19 ET | 2300 | 1.41 |
10:21 ET | 3733 | 1.4 |
10:26 ET | 2000 | 1.4074 |
10:28 ET | 400 | 1.4 |
10:35 ET | 250 | 1.4 |
10:42 ET | 19672 | 1.39 |
10:44 ET | 1422 | 1.39 |
10:46 ET | 100 | 1.395 |
10:48 ET | 800 | 1.395 |
10:51 ET | 5126 | 1.395 |
10:55 ET | 5362 | 1.395 |
11:02 ET | 100 | 1.395 |
11:04 ET | 2495 | 1.39 |
11:06 ET | 2000 | 1.3971 |
11:08 ET | 100 | 1.39 |
11:09 ET | 200 | 1.395 |
11:11 ET | 400 | 1.39 |
11:18 ET | 2400 | 1.39 |
11:20 ET | 100 | 1.39 |
11:22 ET | 200 | 1.395 |
11:24 ET | 200 | 1.395 |
11:26 ET | 5443 | 1.4 |
11:29 ET | 1340 | 1.405 |
11:31 ET | 100 | 1.405 |
11:36 ET | 5868 | 1.39 |
11:38 ET | 420 | 1.395 |
11:42 ET | 400 | 1.395 |
11:45 ET | 400 | 1.4 |
11:49 ET | 300 | 1.395 |
11:54 ET | 125 | 1.3985 |
11:56 ET | 1194 | 1.3905 |
12:00 ET | 750 | 1.4 |
12:02 ET | 920 | 1.4 |
12:05 ET | 3000 | 1.395 |
12:07 ET | 300 | 1.395 |
12:09 ET | 57874 | 1.395 |
12:12 ET | 500 | 1.3901 |
12:14 ET | 100 | 1.395 |
12:16 ET | 100 | 1.395 |
12:18 ET | 2230 | 1.395 |
12:21 ET | 12108 | 1.382 |
12:23 ET | 2800 | 1.3874 |
12:25 ET | 100 | 1.385 |
12:30 ET | 500 | 1.3801 |
12:32 ET | 400 | 1.385 |
12:34 ET | 100 | 1.38 |
12:36 ET | 3722 | 1.38 |
12:38 ET | 2974 | 1.38 |
12:39 ET | 9916 | 1.375 |
12:41 ET | 12468 | 1.37 |
12:43 ET | 700 | 1.37 |
12:48 ET | 5094 | 1.37 |
12:50 ET | 11400 | 1.375 |
12:56 ET | 1000 | 1.3797 |
12:57 ET | 1700 | 1.38 |
12:59 ET | 300 | 1.38 |
01:01 ET | 100 | 1.375 |
01:06 ET | 500 | 1.37 |
01:08 ET | 5002 | 1.375 |
01:10 ET | 300 | 1.375 |
01:12 ET | 16994 | 1.39 |
01:17 ET | 500 | 1.38 |
01:21 ET | 396 | 1.3895 |
01:28 ET | 300 | 1.3895 |
01:30 ET | 1700 | 1.385 |
01:32 ET | 1598 | 1.38 |
01:33 ET | 100 | 1.3819 |
01:37 ET | 100 | 1.385 |
01:39 ET | 1700 | 1.385 |
01:42 ET | 200 | 1.385 |
01:46 ET | 1800 | 1.383 |
01:48 ET | 600 | 1.385 |
01:50 ET | 200 | 1.385 |
01:51 ET | 300 | 1.385 |
01:53 ET | 700 | 1.385 |
01:55 ET | 100 | 1.385 |
01:57 ET | 2100 | 1.385 |
02:02 ET | 300 | 1.3847 |
02:04 ET | 2038 | 1.39 |
02:06 ET | 3600 | 1.39 |
02:08 ET | 9550 | 1.395 |
02:09 ET | 1100 | 1.4 |
02:11 ET | 430 | 1.4 |
02:15 ET | 100 | 1.4 |
02:18 ET | 300 | 1.4 |
02:20 ET | 500 | 1.3983 |
02:24 ET | 500 | 1.3905 |
02:26 ET | 7206 | 1.41 |
02:27 ET | 4800 | 1.4005 |
02:29 ET | 11257 | 1.4 |
02:31 ET | 13050 | 1.4 |
02:36 ET | 700 | 1.395 |
02:38 ET | 800 | 1.4 |
02:40 ET | 100 | 1.4 |
02:42 ET | 2805 | 1.39 |
02:44 ET | 700 | 1.4 |
02:45 ET | 300 | 1.4 |
02:47 ET | 200 | 1.4 |
02:49 ET | 1636 | 1.4 |
02:51 ET | 1357 | 1.395 |
02:56 ET | 1975 | 1.395 |
02:58 ET | 2568 | 1.395 |
03:00 ET | 600 | 1.395 |
03:02 ET | 285 | 1.395 |
03:03 ET | 11800 | 1.395 |
03:07 ET | 100 | 1.395 |
03:09 ET | 200 | 1.39 |
03:12 ET | 3606 | 1.39 |
03:14 ET | 4353 | 1.39 |
03:16 ET | 11640 | 1.385 |
03:18 ET | 4600 | 1.395 |
03:20 ET | 1350 | 1.395 |
03:21 ET | 266 | 1.395 |
03:23 ET | 100 | 1.39 |
03:25 ET | 200 | 1.39 |
03:32 ET | 2600 | 1.392 |
03:36 ET | 1708 | 1.39 |
03:38 ET | 700 | 1.395 |
03:39 ET | 600 | 1.392 |
03:41 ET | 558 | 1.395 |
03:43 ET | 1600 | 1.39 |
03:45 ET | 700 | 1.39 |
03:48 ET | 2403 | 1.39 |
03:50 ET | 1278 | 1.39 |
03:52 ET | 1400 | 1.39 |
03:54 ET | 5968 | 1.39 |
03:56 ET | 5738 | 1.39 |
03:57 ET | 15567 | 1.395 |
03:59 ET | 78205 | 1.41 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
CytomX Therapeutics Inc | 110.6M | 7.1x | --- |
Spero Therapeutics Inc | 76.4M | 3.4x | --- |
2Seventy Bio Inc | 228.2M | -1.1x | --- |
Rigel Pharmaceuticals Inc | 175.2M | -9.3x | --- |
Fortress Biotech Inc | 43.3M | -0.3x | --- |
G1 Therapeutics Inc | 166.8M | -5.3x | --- |
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company focused on developing novel conditionally activated biologics designed to be localized to the tumor microenvironment. It is advancing potential first-in-class and best-in-class antibody-based therapeutics created using its PROBODY therapeutic technology platform. Its pipeline comprises therapeutic candidates across multiple treatment modalities including antibody-drug conjugates (ADCs), T-cell engagers, and immune modulators such as cytokines. Its clinical-stage pipeline includes CX-904, CX-2051 and CX-801. CX-904 is a conditionally activated T-cell-engaging antibody targeting the epidermal growth factor receptor on tumor cells and the CD3 receptor on T cells and partnered with Amgen in a global co-development alliance. CX-2051 is a conditionally activated ADC directed toward epithelial cell adhesion molecule (EpCAM) with potential applicability across multiple EpCAM-expressing epithelial cancers.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $110.6M |
---|---|
Revenue (TTM) | $119.2M |
Shares Outstanding | 77.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.08 |
EPS | $0.20 |
Book Value | $-0.70 |
P/E Ratio | 7.1x |
Price/Sales (TTM) | 0.9 |
Price/Cash Flow (TTM) | 6.0x |
Operating Margin | 9.08% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.